High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris.
Clicks: 361
ID: 60022
2009
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.2
/100
361 views
54 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #6 of 32 articles by views in biotechnology letters
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Staphylokinase (SAK) is a promising thrombolytic agent for treating blood-clotting disorders. Recombinant SAK (rSAK) was produced after integration of the gene into Pichia pastoris genome. The recombinant Pichia carrying multiple insertions of the SAK gene yielded high-level (approximately 1 g/l) of extracellular glycosylated rSAK (approximately 18 kDa) with negligible plasminogen activation activity. Addition of tunicamycin during the induction phase resulted in expression of non-glycosylated and highly active rSAK (approximately 15 kDa) from the same clone. Two simple steps of ion-exchange chromatography produced an homogenous rSAK of >95% purity which suitable for future structural and functional studies.
| Reference Key |
aptedeshpnade2009highlevelbiotechnology
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Apte-Deshpnade, Anjali;Mandal, Goutam;Soorapaneni, Sudheerbabu;Prasad, Bhaskarjyoti;Kumar, Jitendra;Padmanabhan, Sriram; |
| Journal | biotechnology letters |
| Year | 2009 |
| DOI |
10.1007/s10529-009-9938-z
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.